-+ 0.00%
-+ 0.00%
-+ 0.00%

CINGULATE PRESENTS POSITIVE PHASE 3 RESULTS FOR CTX-1301 DEMONSTRATING STATISTICALLY SIGNIFICANT EFFICACY AND ENTIRE ACTIVE-DAY SYMPTOM CONTROL

Reuters·10/28/2025 12:00:11

Please log in to view news